PHILADELPHIA & CARLSBAD, Calif.–(BUSINESS WIRE)–Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that they have entered into a new partnership to bring advanced diagnostics based on analysis of the three-dimensional structure of DNA into broad clinical practice. The collaboration with Fox Chase and its Cancer Epigenetics Institute will help physicia
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
